Risk factors for adverse cardiac events after thoracic surgery in patients with coronary heart disease
10.3760/cma.j.cn131073.20221216.00308
- VernacularTitle:冠心病患者胸科手术后心脏不良事件发生的危险因素
- Author:
Xiaofei WANG
1
;
Mingyang SUN
;
Wei ZHANG
;
Jiaqiang ZHANG
Author Information
1. 河南省人民医院（郑州大学人民医院）麻醉与围术期医学科，郑州 450003
- Keywords:
Coronary disease;
Surgical procedures, operative;
Heart;
Risk factors
- From:
Chinese Journal of Anesthesiology
2023;43(3):293-296
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To identify the risk factors for adverse cardiac events after thoracic surgery in the patients with coronary heart disease.Methods:Perioperative data of patients with coronary heart disease who underwent elective thoracic surgery and had undergone coronary CT angiography before surgery from January 2020 to June 2022 were retrospectively collected. The number and stenosis score of coronary artery were obtained from preoperative coronary artery CT angiography. The patients were divided into cardiac adverse event group and non-cardiac adverse event group according to the occurrence of cardiac adverse events after thoracic surgery from the end of surgery to discharge. Multivariate logistic regression analysis was used to identify the risk factors for adverse cardiac events after thoracic surgery in the patients with coronary heart disease.Results:A total of 786 patients were finally enrolled, and the incidence of cardiac adverse events was 19.6% after thoracic surgery in the patients with coronary heart disease. The results of logistic regression analysis showed that age, preoperative arrhythmia, preoperative coronary stenosis score >7, coronary stent implantation, intraoperative infusion volume, intraoperative red blood cell infusion were risk factors for adverse cardiac events after thoracic surgery in the patients with coronary heart disease ( P<0.05). Conclusions:Age, preoperative arrhythmia, preoperative coronary stenosis score>7, coronary stent implantation, intraoperative infusion volume, intraoperative red blood cell infusion are risk factors for cardiac adverse events after thoracic surgery in the patients with coronary heart disease.
